Free Trial
LON:FARN

Faron Pharmaceuticals Oy (FARN) Share Price, News & Analysis

Faron Pharmaceuticals Oy logo
GBX 185 +10.00 (+5.71%)
As of 10/24/2025 11:46 AM Eastern

About Faron Pharmaceuticals Oy Stock (LON:FARN)

Advanced

Key Stats

Today's Range
175
195
50-Day Range
170.10
235
52-Week Range
140
270
Volume
145,938 shs
Average Volume
39,364 shs
Market Capitalization
£207.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FARN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Faron Pharmaceuticals Oy and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FARN Stock News Headlines

Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
3 UK Growth Companies With High Insider Ownership To Watch
See More Headlines

FARN Stock Analysis - Frequently Asked Questions

Faron Pharmaceuticals Oy's stock was trading at GBX 207 at the start of the year. Since then, FARN shares have decreased by 10.6% and is now trading at GBX 185.

Shares of FARN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Faron Pharmaceuticals Oy investors own include Horizon Discovery Group plc (HZD.L) (HZD), Greencore Group (GNC), Premier African Minerals (PREM), Babcock International Group (BAB), Barclays (BARC), B&M European Value Retail (BME) and Coats Group (COA).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:FARN
CIK
N/A
Fax
N/A
Employees
34
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£60.23 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
0.46%
Return on Assets
-70.00%

Debt

Debt-to-Equity Ratio
922.55
Current Ratio
1.45
Quick Ratio
1.09

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 9.25 per share
Price / Cash Flow
20.00
Book Value
GBX 1,957.36 per share
Price / Book
0.09

Miscellaneous

Outstanding Shares
111,955,000
Free Float
N/A
Market Cap
£207.12 million
Optionable
Not Optionable
Beta
0.36
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (LON:FARN) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners